Impact of DNA methylation on trophoblast function

Clinical Epigenetics

Volumn 3, Issue 3, 2011, Pages

  Serman, L ^a,b   Dodig, D ^a,b  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b Office of Family Medicine ^*  (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869500635     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1186/1868-7083-3-7     Document Type: Review

References (62)

1. Guerrero Bosagna CM, Skinner MK: Epigenetic transgenerational effects of endocrine disruptors on male reproduction. Semin Reprod Med 2009, 27:403-408.
2. Kaverne EB, Curley JP: Epigenetics, brain evolution and behaviour. Front Neuroendocrinol 2008, 29:398-412.
3. Berger SL: The complex language of chromatinregulation during transcription. Nature 2007, 447:407-412.
4. Bird A: Perceptions of epigenetics. Nature 2007, 447:396-398.
5. Kiefer JC: Epigenetics in Development. Dev Dyn 2007, 236:1144-1156.
6. Serman A, Vlahovic M, Serman Lj, Bulic-Jakus F: DNA methylation as a regulatory mechanism for gene expression in mammals. Coll Antropol 2006, 30:665-671.
7. Wang Y, Wysocka J, Sayegh J, Lee YH, Perlin JR, Leonelli L, Sonbuchner LS, McDonald CH, Cook RG, Dou Y, Roeder RG, Clarke S, Stallcup MR, Allis CD, Coonrod SA: Human PAD4 regulates histone arginine methylation levels via demethylation. Science 2004, 306:279-283.
8. Fuks F: DNA methylation and histone modifications: teaming up to silence genes. Curr Opin Genet Dev 2005, 15:52218-52226.
9. αINK4genes in relation to prognosis and tumor characteristics in cervical cancer patients. Int J Oncol 2011, 39(3):683-8.
10. Song Y, Zhang C: Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression. Cancer Chemother Pharmacol 2009, 63:605-613.
11. Hesson L, Dallol A, Minna JD, Maher ER, Latif F: NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 2003, 22:947-954.
12. Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Hoog A, Clark GJ, Ekstrom TJ, Backdahl M, Farnebo F, Larsson C: The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma. Endocr Relat Cancer 2007, 14:125-134.
13. Serman A, Serman L: Development of placenta in a rodent - model for human placentation. Front Biosci (Elite Ed) 2011, 3:233-239.
14. Rossant J, Cross JC: Placental development: Lessons from mouse mutants. Nat Rev Genet 2001, 2:538-548.
15. Loregger T, Pollheimer J, Knöfler M: Regulatory transcription factors controlling function and differentiation of human trophoblast - a review. Placenta 2003,, Suppl A: S104-110.
16. Alders M, Hodges M, Hadjantonakis AK, Postmus J, van Wijk I, Bliek J, de Meulemeester M, Westerveld A, Guillemot F, Oudejans C, Little P, Mannens M: The human Achaete-Scute homologue 2 (ASCL2, HASH2) maps to chromosome 11p15.5, close to IGF2 and is expressed in extravillus trophoblasts. Hum Mol Genet 1997, 6:859-867.
17. Meinhardt G, Husslein P, Knöfler M: Tissue-specific and ubiquitous basic helix-loop-helix transcription factors in human placental trophoblasts. Placenta 2005, 26:527-539.
18. Baczyk D, Drewlo S, Proctor L, Dunk C, Lye S, Kingdom J: Glial cell missing- 1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ 2009, 16:719-727.
19. Novakovic B, Rakyan V, Ng HK, Manuelpillai U, Dewi C, Wong NC, Morley R, Down T, Beck S, Craig JM, Saffery R: Specific tumour-associated methylation in normal human term placenta and first-trimester cytotrophoblasts. Mol Hum Reprod 2008, 14:547-554.
20. Novakovic B, Wong NC, Sibson M, Ng HK, Morley R, Manuelpillai U, Down T, Rakyan VK, Beck S, Hiendleder S, Roberts CT, Craig JM, Saffery R: DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta. J Biol Chem 2010, 285:9583-9593.
21. Ng NK, Novakovic B, Hiendleder S, Craig JM, Roberts CT, Saffery R: Distinct patterns of gene-specific mathylation in mammalian placentas: Implications for placental evolution and function. Placenta 2010, 31:259-268.
22. Gama-Sosa MA, Wang RY, Kuo KC, Gehrke CW, Ehrlich M: The 5-methylcitosine content of highly repeated sequences in human DNA. Nucleic Acids Res 1983, 11(10):3087-95.
23. Tsien F, Youn ES, Long TI, Laird PW, Weissbecker K, Ehrlich M: Prolonged culture of normal chorionic villus cells yields ICF syndrome-like chromatin decomdensation and rearrangements. Cytogenet Genome Res 2002, 98:13-21.
24. Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Mikura K, Miyazaki T, Ogura C, Okazaki Y, Jinno Y: Age related changes in 5- methylcitosine content in human peripheral leukocytes and placentas: an HPLC-base study. Ann Hunter Genet 2004, 68:196-204.
25. Baylin SB: DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol 2005, 2:54-11.
26. Issa JP: CpG island methylator phenotype in cancer. Nat Rev Cancer 2004, 4:988-993.
27. Esteller M, Herman JG: Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 2002, 196:1-7.
28. Waschal A, Feil R: Genomic imprinting in the placenta. Cytogenet Genome Res 2006, 4:90-98.
29. Monk D, Arnaud P, Apostolidou S, Hills FA, Kelsey G, Stanier P, Feil R, Moore GE: Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci USA 2006, 103:6623-6628.
30. Guilleret I, Osterheld MC, Braunschweig R, Gastineau V, Taillens S, Benhattar J: Imprinting of tumor-suppressor genes in human placenta. Epigenetics 2009, 4 :62-68.
31. Grati FR, Sirchia SM, Gentilin B, Rossella F, Ramoscelli L, Antonazzo P, Cavallari U, Bulfamante G, Cetin I, Simoni G, Miozzo M: Biparental expression of ESX1L gene in placentas from normal and intrauterine growth-restricted pregnancies. Eur J Hum Genet 2004, 12:272-278.
32. Murthi P, Doherty VL, Said JM, Donath S, Brennecke SP, Kalionis B: Homeobox gene ESX1L expression is decreased in human pre-term idiopathic fetal growth restriction. Mol Hum Reprod 2006, 12:335-340.
33. Chiu RW, Chim SS, Wong IH, Wong CS, Lee WS, To KF, Tong JH, Yuen RK, Shum AS, Chan JK, Chan LY, Yuen JW, Tong YK, Weier JF, Ferlatte C, Leung TN, Lau TK, Lo KW, Lo YM: Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol 2007, 170:941-50.
34. Pijnenborg R, Vercruysse L: Mathias Duval on placental development in mice and rats. Placenta 2006, 27:109-118.
35. Lo YMD, Corbetta N, Chamberlain PF, Sargent JL: Presence of fetal DNA in maternal plasma and serum. Lancet 1997, 350:485-487.
36. Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, Soothill PW: Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 2007, 27:415-418.
37. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM: Hypermethylated RASSF1A in maternal plasma: A universal fetal DNA marker that impoves the reliability of noninvasive prenatal diagnosis. Clin Chem 2006, 52 :2211-8.
38. Tsui DW, Chan KC, Chim SS, Chan LW, Leung TY, Lau TK, Lo YM, Chiu RW: Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn 2007, 27:1212-1218.
39. Hemberger M: Genetic - epigenetic intersection in trophoblast differentiation: implications for extraembryonic tissue function. Epigenetics 2009, 5(1):24-9.
40. Asanoma K, Rumi MA, Kent LN, Chakraborty D, Renaud SJ, Wake N, Lee DS, Kubota K, Soares MJ: FGF4-dependent stem cells derived from rat blastocysts differentiate along the trophoblast lineage. Dev Biol 2011, 351:110-119.
41. Wu T, Wang H, He J, Kang L, Jiang Y, Liu J, Zhang Y, Kou Z, Liu L, Zhang X, Gao S: Reprogramming of trophoblast stem cells into pluripotent stem cells by Oct4. Stem Cells 2011, 29:755-763.
42. Patra SK, Patra A, Rizzi F, Ghosh TC, Bettuzzi S: Demethylation of (Citosine-5-C-methyl) DNA and regulation of transcription in the epigenetic pathways of cancer development. Cancer Metastasis Rev 2008, 27:315-334.
43. Muller A, Florek M: 5-azacytidine/Azacitidine. Recent Results Cancer Res 2010, 184:159-170.
44. Fenaux P, Bowen D, Gattermann N, Hellstrom-Lindberg E, Hofmann WK, Pfeilstocker M, Sanz G, Santini V: Practical use of azacitidine in higher-risk myelodysplastic syndromes: An expert panel opinion. Leuk Res 2010, 34:1410-1416.
45. De Jesus Romero-Prado MM, Barrera-Saldana HA, Castrillo-Diez JL: hGH-V gene expression and promoter activity under glucose and 5-azacytidine (5azaC) effects. Gene 2010, 452:7-15.
46. Goren A, Simchen G, Fibach E, Szabo PE, Tanimoto K, Chakalova L, Pfeifer GP, Fraser PJ, Engel JD, Cedar H: Fine tuning of globin gene expression by DNA methylation. PloS One 2006, e46.
47. Veljkovic E, Jiricny J, Menigatti M, Rehrauer H, Han W: Chronic exposure to cigarette smoke condensate in vitro induces epithelial to mesenchymal transition-like changes in human bronchial cells, BEAS-2B. Toxicology in Vitro 2011, 25:446-453.
48. Komashko VM, Farnham PJ: 5-azacytidine treatment reorganizes genomic histone modification patterns. Epigenetics 2010, 5:229-240.
49. Patra SK, Bettuzzi S: Epigenetic DNA-(cytosine-5-carbon) modifications: 5-aza-2 deoxycytidine and DNA-demethylation. Biochemistry (Mosc) 2009, 74:613-619.
50. Serman Lj, Vlahovic M, Sijan M, Bulic-Jakus F, Serman A, Sincic N, Matijevic R, Juric-Lekic G, Katusic A: The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta 2007, 28:803-811.
51. Reinhart B, Chaillet R: Genomic imprinting: cis-acting sequences and regional control. Int Rev Cytol 2005, 243:173-213.
52. DeChiara TM, Robertson EJ, Efstratiadis A: Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991, 64(4):849-59.
53. Delaval K, Feil R: Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev 2004, 14(2):188-95.
54. Imamura T, Miyauchi-Senda N, Tanaka S, Shiota K: Identification of genetic and epigenetic similarities of SPHK1/Sphk1 in mammals. J Vet Med Sci 2004, 66(11):1387-93.
55. Reinhart B, Eljanne M, Chaillet JR: Shared role for differentially methylated domains of imprinted genes. Mol Cell Biol 2002, 22(7):2089-98.
56. Vu TH, Li T, Nguyen D, Nguyen BT, Yao XM, Hu JF, Hoffman AR: Symmetric and asymmetric DNA methylation in the human IGF2-H19 imprinted region. Genomics 2000, 64(2):132-43.
57. Ferguson-Smith AC: Genetic imprinting: silencing elements have their say. Curr Biol 2000, 10(23):R872-5.
58. Charalambous M, Menheniott TR, Bennett WR, Kelly SM, Dell G, Dandolo L, Ward A: An enhancer element at the Igf2/H19 locus drives gene expression in both imprinted and non-imprinted tissues. Dev Biol 2004, 271(2):488-97.
59. Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, Docquier F, Farrar D, Tavoosidana G, Mukhopadhyay R, Kanduri C, Oshimura M, Feinberg AP, Lobanenkov V, Klenova E, Ohlsson R: Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 2004, 36(10):1105-10.
60. Sasamoto H, Nagasaka T, Notohara K, Ozaki K, Isozaki H, Tanaka N, Matsubara N: Allele-specific methylation analysis on upstream promoter region of H19 by methylation-specific PCR with confronting two-pair primers. Int J Oncol 2004, 25(5):1273-8.
61. Rishi V, Bhattaxharya P, Chatterjee R, Rozenberg J, Zhao J, Glass K, Fitzgerald P, Vinson C: CpG methylation on half-CRE sequences creates C/EBPa binding sites that activates some tissue-specific genes. PNAS 2010, 107:20311-20316.
62. Serman L, Serman A, Fabijanovic D: An in vivo rat model to study epigenetic control of cell invasion. Med Hypotheses 2011, 76(3):407-9.